Monitor for upcoming Q1 financial confirmation and any disclosure of new contract wins or backlog growth. The engagement with Fortune 500 life sciences firms and a confirmed integration project suggest improving commercial traction—watch for follow-up announcements on revenue conversion from this pipeline in the next 60–90 days.
Price Chart
Executive Summary
TOMI Environmental Solutions highlighted strong engagement at INTERPHEX 2026, reporting over 200 interactions with current and prospective customers, including major life sciences firms like Moderna, Merck, and Sanofi. The company announced it finalized timelines with a new prominent healthcare client to integrate its SteraMist iHP technology into the client’s proprietary container system, signaling growing market acceptance beyond product validation. While no financial figures were disclosed, management emphasized an inflection point in scaling operations to meet rising demand.
Key Facts
- TOMI exhibited at INTERPHEX 2026, a key life sciences industry trade show, engaging with over 200 current and potential customers.
- Major companies including Amgen, Bayer, Moderna, Merck, Regeneron, and Sanofi visited TOMI's booth.
- Company finalized integration timelines with a new U.S.-based healthcare client for iHP decontamination in its proprietary container system for premixed medications.
- Management stated the event reflects a shift from product validation to broad market acceptance and a critical inflection point for scaling.
- No specific financials (revenue, contract value, or backlog) were disclosed in the release.
Financial Impact
Undisclosed; however, the integration project and expanded pipeline suggest potential near-term revenue visibility.
Risk Factors
- No financial metrics were provided, making it difficult to assess actual revenue impact.
- Forward-looking statements dominate the release; execution risk remains high given TOMI's small size and history of inconsistent revenue scaling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3281611 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 8-K | $1.44 | awaiting T+20 | — | $1.49 (+3.47%) |
Oct 15, 2026 12d ago | Press Release | $1.50 | awaiting T+20 | — | $1.49 (−0.67%) |
Oct 1, 2026 26d ago | Press Release | $1.36 | awaiting T+20 | — | $1.49 (+9.56%) |
Sep 21, 2026 5w ago | 8-K | $1.46 $1.47 | ▲ +0.68% | ▲ +1.24% | $1.49 (+2.05%) |
Sep 21, 2026 5w ago | Press Release | $1.46 $1.47 | ▲ +0.68% | ▲ +1.24% | $1.49 (+2.05%) |
Sep 18, 2026 5w ago | Press Release | $1.46 $1.47 | ▲ +0.68% | ▲ +0.48% | $1.49 (+2.05%) |
Sep 2, 2026 7w ago | 8-K | $1.66 $1.36 | ▼ −18.07% | ▼ −17.92% | $1.49 (−10.24%) |
Aug 14, 2026 10w ago | 8-K | $1.75 $1.58 | ▼ −9.71% | ▼ −7.72% | $1.49 (−14.86%) |
Aug 14, 2026 10w ago | Press Release | $1.75 $1.58 | ▼ −9.71% | ▼ −7.72% | $1.49 (−14.86%) |
Jul 29, 2026 12w ago | 8-K | $1.52 $1.73 | ▲ +13.82% | ▲ +8.80% | $1.49 (−1.97%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers